Veterinary Antimicrobial Susceptibility Testing in Australia Trends and Forecast
The future of the veterinary antimicrobial susceptibility testing market in Australia looks promising, with opportunities in the veterinary reference laboratory and veterinary research institutes & universities markets. The global veterinary antimicrobial susceptibility testing market is expected to reach an estimated $59.2 billion by 2031, with a CAGR of 6.3% from 2025 to 2031. The veterinary antimicrobial susceptibility testing market in Australia is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the escalating danger of antimicrobial resistance is a result of the excessive use of antibiotics, increasing demand for animal-derived products, and rising prevalence of zoonotic diseases.
• Lucintel forecasts that, within the animal type category, food-producing animal is expected to witness the higher growth over the forecast period.
• Within the end use category, veterinary reference laboratories is expected to witness the highest growth.
Emerging Trends in the Veterinary Antimicrobial Susceptibility Testing Market in Australia
Australia is experiencing rapid change in the veterinary antimicrobial susceptibility testing market, driven primarily by increased awareness of antimicrobial resistance, rising regulatory pressure, and the adoption of advanced diagnostic technologies. With the growth of both companion animal and livestock industries, there is mounting pressure to provide fast, accurate, and scalable testing solutions. Veterinary professionals are now integrating automated workflows, point-of-care platforms, and data analytics to enhance diagnosis and guide more targeted antibiotic use. These emerging trends align with global One Health policies and national antimicrobial stewardship plans, transforming how animal health services are delivered and how resistance patterns are managed across the country.
• Automated AST systems: Automated high-throughput platforms such as microdilution systems are increasingly popular for their ability to minimize human error, improve sample consistency, and generate faster standardized results. These technological advancements support veterinary laboratories in meeting the rising demand for efficiency and accuracy, particularly in high-volume settings. Automation enhances overall laboratory productivity and adherence to updated regulatory guidelines aimed at reducing antibiotic misuse. The increasing use of machine learning and robotics is redefining the role and capabilities of diagnostic laboratories.
• Point of care rapid testing: Portable AST devices capable of delivering results in under one hour are seeing increased adoption, particularly in rural clinics and mobile veterinary practices. These rapid tools assist veterinarians in making faster treatment decisions in field environments and emergencies. They help reduce the unnecessary use of broad-spectrum antibiotics and promote more appropriate treatment choices. These devices are especially critical in time-sensitive livestock settings where treatment delays can affect animal welfare and farm productivity.
• Digital data-driven platforms: The implementation of cloud-based diagnostic platforms and artificial intelligence is supporting real-time monitoring of resistance patterns, improving response strategies, and long-term planning. These platforms allow veterinarians and laboratories to analyze trends, compare treatment protocols, and share data across networks. This strengthens national antimicrobial resistance surveillance programs and contributes to predictive modeling for outbreaks and resistance risks. Increased data transparency improves coordination between animal health services and regulatory authorities.
• Companion animal test focus: Rising pet ownership in urban and suburban areas has led to a strong demand for AST services tailored specifically for companion animals. Clinics are increasingly detecting antimicrobial resistance in pathogens such as Escherichia coli and Staphylococcus species in cats and dogs. This has driven demand for customized diagnostic panels and rapid testing for small animals. This growth is also influencing product development efforts by pet healthcare companies focused on innovation and efficiency.
• Reference laboratory expansion: Investments in expanding and modernizing veterinary reference laboratories across Australia are providing broader access to high-quality AST services. These laboratories are equipped with automated technologies, enhanced logistics systems, and trained staff to serve both private practices and public health programs. Centralized testing models reduce turnaround times, improve reporting accuracy, and ensure consistent quality standards. These facilities also serve as central data repositories for national AMR surveillance and collaborative research initiatives.
These emerging trends are reshaping the veterinary antimicrobial susceptibility testing market in Australia by enabling faster diagnostics, improving data-driven decision-making, supporting better antibiotic stewardship, and expanding access to specialized care. Together, they are creating a more resilient and responsive ecosystem for managing animal health and antimicrobial resistance.
Recent Developments in the Veterinary Antimicrobial Susceptibility Testing Market in Australia
Over the past few years, the Australian veterinary antimicrobial susceptibility testing market has undergone significant advancements in technology, laboratory infrastructure, and policy. These improvements are focused on delivering more precise, faster, and accessible diagnostic solutions for both livestock and companion animals. Enhanced diagnostic tools, upgraded laboratory capabilities, and strengthened public-private partnerships are contributing to a more effective veterinary health system. These changes align with the national AMR response strategy, equipping veterinarians to manage increasing clinical demands while supporting responsible antimicrobial use.
• AI-based AST platform launches: Diagnostic firms introduced AI-powered AST systems in early 2025 that provide automated interpretation of resistance and pathogen profiling. These platforms use advanced algorithms to increase diagnostic accuracy, reduce turnaround times, and minimize manual intervention. Their use in centralized and private veterinary laboratories has significantly improved efficiency while supporting more informed antibiotic prescribing. These tools are especially useful in managing chronic infections and complex bacterial cases by delivering detailed diagnostic data with reduced human error.
• Molecular rapid testing systems: New point-of-care diagnostic tools using molecular techniques such as PCR and isothermal amplification are now widely available. These systems detect genetic markers of resistance directly from clinical samples, delivering results within 30 to 60 minutes. This capability is particularly valuable in veterinary clinics where immediate treatment decisions are critical. These systems help reduce unnecessary antimicrobial prescriptions and support targeted therapy, improving treatment effectiveness in pets and livestock.
• Advanced reference laboratory facilities: Increased government and private funding has led to the development of state-of-the-art reference laboratories across Australia. These facilities feature specialized AST departments, automated instruments, experienced microbiologists, and optimized logistics systems for sample handling and result reporting. They play a vital role in expanding diagnostic access, particularly in remote and underserved regions. This infrastructure also enables deeper integration with national AMR monitoring efforts.
• Update of regulatory guidelines: National veterinary bodies have issued updated guidelines on antimicrobial use and AST that align with global One Health principles. These guidelines emphasize mandatory AST for certain infections, standardized result formats, and improved data reporting. Compliance with these guidelines is now linked to licensing and funding eligibility, fostering accountability among veterinary service providers. The revised standards promote consistent, transparent, and effective antibiotic use across the veterinary sector.
• One Health integration: Veterinary AST data is now being integrated into larger surveillance networks that include human and environmental health information. This integration allows authorities to track antimicrobial resistance trends across species and regions. It enables coordinated responses to emerging resistance threats and supports research and policy development. Improved data interoperability and standardized procedures have enhanced the effectiveness of national resistance surveillance.
Recent developments in Australian veterinary antimicrobial susceptibility testing market are enhancing diagnostic capabilities, improving regulatory compliance, and promoting collaborative practices across sectors. These advances enable veterinarians to make informed treatment decisions and support national efforts to combat antimicrobial resistance while improving animal health outcomes.
Strategic Growth Opportunities for Veterinary Antimicrobial Susceptibility Testing Market in Australia
Australian veterinary antimicrobial susceptibility testing market is undergoing strategic growth through the expansion of high-impact applications. These include precision livestock management, rural service outreach, species-specific diagnostics, digital platforms, and multi-sector collaboration. Each of these areas offers substantial opportunities to increase testing volumes, improve diagnostic accuracy, and support better animal health. These initiatives also promote responsible antimicrobial use in alignment with national health priorities and economic goals of the veterinary and agricultural sectors.
• Precision livestock production: Integrating AST into herd health and farm management programs enables evidence-based antibiotic decisions, reducing the need for mass medication. This approach improves productivity and limits treatment failures. On-site diagnostics and digital recordkeeping also support epidemiological tracking and benchmarking, making this area a key growth driver for veterinary diagnostic providers and farm management systems.
• Regional testing centers: Mobile units and regional laboratories are increasing diagnostic access in rural and agricultural regions. These facilities process local samples promptly, reducing delays and improving health outcomes. They offer a cost-effective alternative to central labs and benefit small-scale farmers. Government support and agricultural partnerships are critical in building the infrastructure and training required for these regional hubs.
• Exotic pet and companion animal niches: Rising interest in exotic pets and wildlife is creating demand for customized AST services. Clinics treating reptiles, birds, and zoo animals require specialized susceptibility panels. Diagnostic firms are developing adaptable test kits and providing tailored consulting services to meet this demand. The niche market is growing steadily and presents significant opportunities due to its specialized nature and expanding clientele.
• Digital knowledge platforms: Online AST result portals and mobile applications are providing veterinarians with instant access to test data, regional resistance patterns, and treatment guidelines. These platforms also support data sharing, performance benchmarking, and integration with patient history. They improve clinical efficiency, enhance communication with clients, and support continuing education through real-time evidence-based insights.
• Public-private partnerships: Strategic collaborations between diagnostic companies, research institutes, and government agencies are accelerating innovation in AST technology. These partnerships fill funding gaps, speed up development cycles, and support pilot programs in underserved areas. Collaborative efforts ensure alignment with public health priorities and help standardize tools and protocols across the veterinary sector.
Strategic growth opportunities in Australian veterinary antimicrobial susceptibility testing market are fostering a more inclusive, advanced, and efficient diagnostic environment. These developments enhance veterinary care, promote sustainable antimicrobial use, and support national efforts to mitigate resistance through improved access and innovation.
Veterinary Antimicrobial Susceptibility Testing Market in Australia Driver and Challenges
Australian veterinary antimicrobial susceptibility testing market is shaped by a complex combination of technological progress, economic priorities, and regulatory dynamics. Key drivers include increasing concern about antimicrobial resistance, ongoing innovation in diagnostics, regulatory reforms, rising demand for companion animal care, and public investment. At the same time, the market faces significant challenges such as high operational costs, data interoperability issues, and limited rural service access. These factors collectively influence the development and adoption of AST services across the country.
The factors responsible for driving the veterinary antimicrobial susceptibility testing market in Australia include:
• Rising alarm over antimicrobial resistance: Growing awareness among veterinarians, producers, and pet owners about the risks of resistance is increasing the demand for routine AST. It is now considered essential for preserving antibiotic effectiveness and ensuring safe treatment practices. Professional training and national awareness campaigns are reinforcing this shift.
• Advances in technology: Emerging diagnostic tools, including automated analyzers, AI-driven platforms, and rapid molecular tests, are transforming the veterinary diagnostic landscape. These innovations lower operational costs, reduce human error, and enable more animals to be tested in less time, increasing market adoption.
• Rules and regulations: Updated policies now require AST before the use of certain antibiotics, particularly in food animals. These rules are linked to public health strategies and trade compliance, encouraging investment in diagnostic capabilities and adherence to best practices.
• Demand for companion animals: As more Australians invest in pet healthcare, there is a rising demand for precise diagnostics to ensure safe and effective treatment. AST is being used more frequently in cases of common infections in dogs and cats, especially in urban clinics.
• Government and industrial assistance: National funding programs, industry grants, and public awareness efforts are driving the adoption of advanced diagnostics. These initiatives have strengthened sector capacity and increased access to high-quality testing services.
Challenges in the veterinary antimicrobial susceptibility testing market in Australia are:
• High cost of implementation: Despite advancements, many veterinary practices cannot afford the upfront investment required for automated and molecular testing systems. This limits access to cutting-edge diagnostics in smaller or rural clinics.
• Limits of data integration: The lack of standardized data systems and incompatible software tools impedes result sharing and surveillance efforts. This creates inefficiencies in monitoring resistance trends at the national level.
• Asymmetrical geographic access: Clinics in remote areas often lack access to diagnostic laboratories, leading to treatment delays and reliance on empirical therapy. Addressing this issue requires targeted infrastructure development and better logistics support.
The combination of strong drivers and persistent challenges is shaping the evolving veterinary antimicrobial susceptibility testing market in Australia. While innovation and demand are pushing the sector forward, overcoming barriers related to cost, data systems, and rural access will be essential for realizing the full benefits of advanced antimicrobial diagnostics.
List of Veterinary Antimicrobial Susceptibility Testing Market in Australia Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, veterinary antimicrobial susceptibility testing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the veterinary antimicrobial susceptibility testing companies profiled in this report include:
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10
Veterinary Antimicrobial Susceptibility Testing Market in Australia by Segment
The study includes a forecast for the veterinary antimicrobial susceptibility testing market in Australia by animal type, product type, and end use.
Veterinary Antimicrobial Susceptibility Testing Market in Australia by Animal Type [Analysis by Value from 2019 to 2031]:
• Food-producing Animals
• Companion Animals
Veterinary Antimicrobial Susceptibility Testing Market in Australia by Product Type [Analysis by Value from 2019 to 2031]:
• Disks & Plates
• Culture Media
• Accessories & Consumables
• Automated AST Instruments
Veterinary Antimicrobial Susceptibility Testing Market in Australia by End Use [Analysis by Value from 2019 to 2031]:
• Veterinary Reference Laboratory
• Veterinary Research Institutes & Universities
• Other
Features of the Veterinary Antimicrobial Susceptibility Testing Market in Australia
Market Size Estimates: Veterinary antimicrobial susceptibility testing in Australia market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Veterinary antimicrobial susceptibility testing in Australia market size by animal type, product type, and end use in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different animal types, product types, and end uses for the veterinary antimicrobial susceptibility testing in Australia.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the veterinary antimicrobial susceptibility testing in Australia.
Analysis of competitive intensity of the industry based on Porters Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What are the major drivers influencing the growth of the veterinary antimicrobial susceptibility testing market in Australia?
Answer: The major drivers for this market are escalating danger of antimicrobial resistance is a result of the excessive use of antibiotics, increasing demand for animal-derived products, and rising prevalence of zoonotic diseases.
Q2. What are the major segments for veterinary antimicrobial susceptibility testing market in Australia?
Answer: The future of the veterinary antimicrobial susceptibility testing market in Australia looks promising with opportunities in the veterinary reference laboratory and veterinary research institutes & universities markets.
Q3. Which veterinary antimicrobial susceptibility testing market segment in Australia will be the largest in future?
Answer: Lucintel forecasts that food-producing animals is expected to witness the higher growth over the forecast period.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 10 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the veterinary antimicrobial susceptibility testing market in Australia by animal type (food-producing animals and companion animals), product type (disks & plates, culture media, accessories & consumables, and automated AST instruments), and end use (veterinary reference laboratory, veterinary research institutes & universities, and other)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Veterinary Antimicrobial Susceptibility Testing Market in Australia, Veterinary Antimicrobial Susceptibility Testing Market in Australia Size, Veterinary Antimicrobial Susceptibility Testing Market in Australia Growth, Veterinary Antimicrobial Susceptibility Testing Market in Australia Analysis, Veterinary Antimicrobial Susceptibility Testing Market in Australia Report, Veterinary Antimicrobial Susceptibility Testing Market in Australia Share, Veterinary Antimicrobial Susceptibility Testing Market in Australia Trends, Veterinary Antimicrobial Susceptibility Testing Market in Australia Forecast, Veterinary Antimicrobial Susceptibility Testing Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.